LIALDA PACKAGE INSERT PDF

Check out Lialda for induction of remission in active mild to moderate UC and maintenance of UC remission. Read safety info including potential kidney. Shire US Manufacturing Inc.: LIALDA is indicated for the induction of remission in patients with active, mild to moderate ulcerative colitis and for. Easy to read FDA package insert, drug facts, dosage and administration, and adverse effects for Lialda (mesalamine).

Author: Bazragore Nidal
Country: Serbia
Language: English (Spanish)
Genre: Life
Published (Last): 22 April 2014
Pages: 212
PDF File Size: 2.55 Mb
ePub File Size: 18.4 Mb
ISBN: 150-1-30259-629-6
Downloads: 5391
Price: Free* [*Free Regsitration Required]
Uploader: Mojinn

All content on this Web site, including text, images, graphics, sound files, and their arrangement, belongs to Shire and is protected by international copyright laws. See Additional Important Safety Information. This link will take you to a Web site maintained by a third party, who is responsible for its content and privacy policy.

Kidney problems have been reported with medications that contain mesalamine, such as Lialda. Your e-mail address and that of the recipient will be used for transmission only and will not be used for any other purposes. You must have JavaScript enabled on your computer to access this Web site feature. If this happens to you, your doctor may tell you to stop taking Lialda. See Full Important Safety Information. Click OK if you are a health care professional.

  ECONOMIA BASICA FRANCISCO MOCHON PDF

The content may not be copied for commercial use or distribution, nor may these objects be downloaded, modified, or posted to other sites. Do not take Lialda mesalamine if you are allergic to salicylates, such as aspirin, or medications that contain aspirin; aminosalicylates; mesalamine; or any other ingredients in Lialda. Please see Full Prescribing Information for Lialda mesalamine.

Please review Shire’s Privacy Policy.

Ulcerative Colitis (UC) Treatment | Lialda® (mesalamine)

E-mail this page or Web site to a friend or loved one by filling out the form below. While Shire US Inc. Following Your Prescribed Treatment Plan. In clinical studies of Lialda, inflammation of the pancreas also occurred. Tell your doctor if you: For the induction of remission in patients with active, mild to moderate ulcerative colitis UC and for the maintenance of remission of UC.

You are encouraged to report negative side effects of prescription drugs to the FDA. The information contained in this section of the site is intended for US health care professionals only. Shire does not control the content of non-Shire Web sites, and this link does not constitute an endorsement by Shire of the site’s content.

This site is intended solely for US residents and is governed solely by US laws and government regulations. Click “Cancel” to return or “OK” to continue.

E-mail this page only. Talk to your doctor about why Lialda may be right for you. Our privacy policy does not apply to this site.

  IEC 62035 PDF

Cookies are required to use some elements of this Web site. All fields are required. You may need to adjust your Internet properties within your Web browser software, such as Microsoft Internet Explorer or Mozilla Firefox.

Your doctor may check to see how your kidneys are working before starting Lialda and periodically while taking Lialda. All other intellectual property rights are reserved. Please see our privacy policy lialdaa more information.

E-mail to a Friend

Important Safety Information Do not take Lialda mesalamine if you are allergic to salicylates, such as aspirin, or medications that contain aspirin; aminosalicylates; mesalamine; or any other ingredients in Lialda. Lialda is a prescription medication approved for the induction of remission in patients with active, mild to moderate ulcerative colitis UC and for the maintenance of remission of UC. We encourage you to read the privacy policy of every Web site you visit.

Find information about UC. E—mail this list of questions for the doctor — to yourself, a friend or a loved one — by filling out the form below.